DeepMed Research

THOMAS JEFFERSON UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1824-01-01

Employees: 10K

Market Cap: -

Website: http://www.jefferson.edu

Clinical Trials

Heart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL Parameters

Terminated

Conditions: Heart Failure

First Posted Date: 2011-05-20

Last Posted Date: 2013-01-07

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 40

Registration Number: NCT01357408

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

A Study of Sternal Closure After Open Heart Surgery: Rigid Versus Wire Closure

Not Applicable

Completed

Conditions: Pain

Interventions: Device: Sternalock Rigid Fixation

First Posted Date: 2011-03-17

Last Posted Date: 2018-02-14

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 80

Registration Number: NCT01317095

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment

Phase 3

Completed

Conditions: Mild Cognitive Impairment (MCI)

Interventions: Behavioral: Supportive Therapy (ST)
Behavioral: Behavioral Activation (BA)

First Posted Date: 2011-02-18

Last Posted Date: 2018-12-12

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 221

Registration Number: NCT01299766

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Incidence of Hyponatremia in PEG-SD Compared to PEG-ELS

Not Applicable

Completed

Conditions: Hyponatremia

Interventions: Drug: PEG-ELS
Drug: PEG-SD

First Posted Date: 2011-02-18

Last Posted Date: 2013-06-05

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 460

Registration Number: NCT01299779

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone

Phase 2

Conditions: Differentiated Thyroid Cancer

Interventions: Drug: Everolimus
Drug: Sorafenib

First Posted Date: 2010-12-21

Last Posted Date: 2021-10-26

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 35

Registration Number: NCT01263951

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

The Effects of Two Functional Electrical Stimulation Cycling Paradigms

Phase 2

Completed

Conditions: Spinal Cord Injury

Interventions: Other: Cycling with functional electrical stimulation

First Posted Date: 2010-11-19

Last Posted Date: 2014-01-08

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 17

Registration Number: NCT01244594

Locations: 🇺🇸
Magee Rehabilitation Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Pilot Study to Collect and Evaluate Data on the Use of IV* Ibuprofen in the Treatment of an Acute Migraine Attack

Phase 4

Completed

Conditions: Episodic Migraine

Interventions: Other: saline placebo
Drug: Ibuprofen

First Posted Date: 2010-10-29

Last Posted Date: 2022-09-06

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 44

Registration Number: NCT01230411

Locations: 🇺🇸
Jefferson Headache Center, Philadelphia, Pennsylvania, United States

Cesarean Trial of Staples vs. Sutures

Not Applicable

Completed

Conditions: Wound Complications
Patient Satisfaction
Cesarean Section
Pain Measurement

Interventions: Other: Staples
Other: Suture

First Posted Date: 2010-09-29

Last Posted Date: 2019-11-26

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 746

Registration Number: NCT01211600

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

The Effects of Moviprep With Simethicone on Colonic Bubbles

Not Applicable

Completed

Conditions: Bubbles in Colon at Time of Colonoscopy

Interventions: Drug: simethicone

First Posted Date: 2010-09-27

Last Posted Date: 2019-07-15

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 140

Registration Number: NCT01209806

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)

Phase 2

Conditions: Sickle Cell Disease
HEMOGLOBIN SS
Hemoglobin S Beta-0 Thalassemia
Inflammation
Quality of Life

Interventions: Other: Placebo Capsules

First Posted Date: 2010-09-16

Last Posted Date: 2010-10-25

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 48

Registration Number: NCT01202812

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
St. Christopher's Hospital for Children, Drexel University, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy